Premium
The A 2B Adenosine Receptor Antagonist Alloxazine Exacerbates NASH and Disrupts Cellular Folate Metabolism in Methionine and Choline Deficient Mice
Author(s) -
Eudy Brandon James,
Silva Robin da
Publication year - 2019
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.2019.33.1_supplement.795.5
Subject(s) - endocrinology , medicine , biology , adenosine , fatty liver , purinergic signalling , lipid metabolism , methionine , steatohepatitis , biochemistry , chemistry , receptor , adenosine receptor , disease , agonist , amino acid
Nonalcoholic fatty liver disease is characterized by hepatic lipid accumulation of greater than 5% and is a rising healthcare problem in the United States. Approximately 25–30% of the US population may have a fatty liver and 10–15% of these patients will progress to more severe disease known as nonalcoholic steatohepatitis (NASH). There are no approved treatments for NASH and the factors that result in the transition from fatty liver to NASH are not well defined. Folate and one‐carbon metabolism are implicated in the pathogenesis of NASH and are important pathways for the biosynthesis of many important molecules like creatine, phosphatidylcholine, purines, and thymidine. Additionally, the purine adenosine modulates immune cells by signaling to cell surface receptors on macrophages in the liver. In the present study, mice were fed a methionine and choline deficient diet to induce NASH lesions and treated with a putative A 2B adenosine receptor antagonist, alloxazine, to probe the role of this adenosine receptor in NASH. MCD diet feeding reduced purine and thymidine nucleotides in the liver; potentially limiting the availability of crucial molecules for regeneration of liver tissue. MCD mice showed reduced activating transcription factor 4 (ATF4) expression, which has been shown to regulate mitochondrial folate metabolism and formate production which is required for purine biosynthesis. Alloxazine treatment exacerbated hepatic lipid accumulation and caused severe lobular inflammation in MCD mice. Alloxazine also disrupted hepatic folate metabolism and reduced the concentration of formate without altering concentrations of S‐adenosylmethionine and S‐adenosylhomocysteine. These data suggest that in addition to its function as an A 2B adenosine receptor antagonist, alloxazine also impairs cellular folate metabolism. These data provide a novel link between folate and lipid metabolism, and inflammation in NASH. This abstract is from the Experimental Biology 2019 Meeting. There is no full text article associated with this abstract published in The FASEB Journal .